Deutsches Krebsforschungszentrum (DKFZ)

Gegenwärtige und zukünftige Therapiestratifizierung des metastasierten Urothelkarzinoms: eine große Chance für eine echte Präzisionsonkologie (2025) Niegisch G, Zschäbitz S, Klümper N, Eckstein M Journal article, Review article Digital twins for personalized treatment in uro-oncology in the era of artificial intelligence (2025) Görtz M, Brandl C, Nitschke A, Riediger A, Stromer D, Byczkowski M, Heuveline V, Weidemüller M Journal article, Review article Optimizing whole-body MRI for early cancer detection in Li-Fraumeni syndrome: a prospective bicentric study (2025) Keymling MM, Kurz FT, Kuder TA, Bickelhaupt S, Hielscher T, Hog R, Mokry T, et al. Journal article Correction to: Genetic drivers and cellular selection of female mosaic X chromosome loss (Nature, (2024), 631, 8019, (134-141), 10.1038/s41586-024-07533-7) (2024) Liu A, Genovese G, Zhao Y, Pirinen M, Zekavat SM, Kentistou KA, Yang Z, et al. Journal article, Erratum Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer (2024) Nelson BH, Hamilton P, Phung MT, Milne K, Harris B, Thornton S, Stevens D, et al. Journal article Prompt gamma emission prediction using a long short-term memory network (2024) Xiao F, Radonic D, Kriechbaum M, Wahl N, Neishabouri A, Delopoulos N, Parodi K, et al. Journal article Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction (2024) Yiangou K, Mavaddat N, Dennis J, Zanti M, Wang Q, Bolla MK, Abubakar M, et al. Journal article Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporation (2024) Soleder S, Gengenbacher N, Mogler C, Eckstein M, Runge A, Kriegmair MC, Augustin HG Journal article DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional Classification (2024) Jurmeister P, Leitheiser M, Arnold A, Capilla EP, Mochmann LH, Zhdanovic Y, Schleich K, et al. Journal article Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER+ breast cancer (2024) Zimmer P, Esser T, Lueftner D, Schuetz F, Baumann FT, Rody A, Schneeweiss A, et al. Journal article